ExoDx Prostate Evaluation in Active Surveillance Patient Population
NCT ID: NCT05572099
Last Updated: 2022-10-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
750 participants
OBSERVATIONAL
2022-10-01
2023-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Evaluation of ExoDx Prostate(IntelliScore) in Men Presenting for Initial Prostate Biopsy
NCT04720599
ExoDx Prostate Evaluation in Prior Negative Prostate Biopsy Setting
NCT04357717
Clinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI)
NCT03031418
Decision Impact Trial of the ExoDx Prostate (IntelliScore)
NCT03235687
Plasma Exosome RNA to Diagnose Prostate Cancer
NCT06604130
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ExoDx Prostate
Observational only.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* History of invasive treatment for benign prostatic hypertrophy with in 6 months of enrollment.
* Known hepatitis or HIV
* History of concurrent renal/bladder tumors
45 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Exosome Diagnostics, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sonia Kumar, PhD
Role: STUDY_DIRECTOR
Exosome Diagnostics, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chesapeake Urology
Towson, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Emily Ayre
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ECT2022-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.